Published in Surgery Litigation and Law Weekly, February 23rd, 2007
PDT, a combination of light therapy and photosensitive topical solution, is often used to treat AKs, a common skin condition that, if left untreated, can lead to squamous cell carcinoma (skin cancer). According to the recommendations, PDT should be considered as a first-line therapy for treating the precancerous lesions. The Levulan PDT system (Levulan Kerastick together with the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.